Tradestie Institutional Equity Comparison Engine

IHE vs IHF โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

IHF Overall Edge

IHF Captures Institutional Edge (2โ€“0 Pillars ยท 3โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to iShares U.S. Healthcare Providers ETF (IHF) driven by superior Momentum & Technical, Options & Structure. Fundamentally, IHE trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus IHF at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, IHE sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against IHF sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IHE N/M vs IHF N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner IHF
1Y +36.9% vs +26.0% ยท 52W Pos 93% vs 96%
Options & Structure Winner IHF
UNCLASSIFIED (5th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
IHE NYSE Arca
iShares U.S. Pharmaceuticals ETF
Institutional Equity
$109.89
-1.03% 1D
Market Cap N/A
1M Return +8.74%
1Y Return +36.93%
Forward P/E N/M
Unified AI Score
39.6 / 100 SELL
Tech 24.0 Fund 37.0 Flow 50.0 Mom 40.0
IHF NYSE Arca
iShares U.S. Healthcare Providers ETF
Institutional Equity
$60.79
+0.63% 1D
Market Cap N/A
1M Return +3.65%
1Y Return +25.96%
Forward P/E N/M
Unified AI Score
47.8 / 100 HOLD
Tech 36.0 Fund 47.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IHE +36.93% IHF +25.96% Spread: +10.97 pp (IHE Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IHE TTM Op. Margin: N/A IHF TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IHE vs IHF. Trailing 12-month operating profitability (IHE N/A vs IHF N/A) and valuation multiples (IHE N/M vs IHF N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IHE (0) vs IHF (3)
Institutional Metric IHE IHF Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 93% ($80โ€“$112) 96% ($41โ€“$62) Stronger Trend IHF
Beta / 30D Volatility Risk Regime 0.40ฮฒ ยท 25% Vol 0.30ฮฒ ยท 18% Vol Lower Realized Risk IHF
Unified Institutional Score Composite Signal 39.6 / 100 (SELL) 47.8 / 100 (HOLD) Higher Composite IHF

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IHE vs IHF Buy Guide
IHE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live IHE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
IHF UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live IHF Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IHE nor IHF registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.